Indoximod: Additional Phase Ib/II data

Data from 31 evaluable treatment-naive patients with metastatic pancreatic cancer in an open-label, U.S.

Read the full 142 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE